Rapid diagnostics continue transforming healthcare delivery worldwide, fueled by aging populations, decentralized care models, technological converge ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

Because COVID-19 is caused by a virus, antibiotics cannot be used to treat it. However, Pulia says physicians may feel they ...

Eli Lilly and Company, Thermo Fisher Scientific, and Pfizer are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are equity shares ...

Acquisitions in Alzheimer’s drug development have soared, with deal value jumping from $2 billion in 2022 to nearly $18 ...

So, Covid-19, our old enemy returns ... early testing is essential. Discuss antiviral medications like Paxlovid with your doctor as soon as possible if you test positive and belong to a high-risk ...

For decades, international researchers have received a small slice of the National Institutes of Health budget. In 2024, out ...

As international research projects are upended, European leaders say they will fill the funding void. Is that realistic?

The virus killed at least 20 million people, wiped at least $10 trillion from the global economy and upended billions of ...

A painful sore throat is a signature symptom of an Omicron subvariant called NB.1.8.1, or Nimbus. It now makes up about a ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

Cases of respiratory illnesses like Covid-19 and influenza have been creeping up as the days get colder. Hospitalisations for ...